| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/06/2002 | CN1334731A Pharmaceutical formulation |
| 02/06/2002 | CN1334730A Vitronectin receptor antagonist |
| 02/06/2002 | CN1334729A Controlled-release dosage forms comprising zolpidem or salt thereof |
| 02/06/2002 | CN1334728A Palladium-substd. bacteriochlorophll derivatives and use thereof |
| 02/06/2002 | CN1334727A Method and composition for treating and preventing tuberculosis |
| 02/06/2002 | CN1334726A Hydroxy diphenyl urea sulfonamides as IL-8 receptor antagonists |
| 02/06/2002 | CN1334725A Parenteral solution of propofol (2,6-diisopropylphenol) and 2,5-di-O-methyl-1,4;3,6-dianhydro-D-glucitol as solvent |
| 02/06/2002 | CN1334724A Nanoparticulate core-shell systems and use thereof in pharmaceutical and cosmetic preparations |
| 02/06/2002 | CN1334723A Improvements in or relating to powder |
| 02/06/2002 | CN1334705A Fibre blend for enteral composition |
| 02/06/2002 | CN1334704A Method and compositions for producing berry derived products |
| 02/06/2002 | CN1334702A Method for treatment of bacterial infections with once or twice-weekly administered rifalazil |
| 02/06/2002 | CN1334122A Medicine for treating HIV infection, its composition and its use |
| 02/06/2002 | CN1334121A Medicinal composition for restoring cardiac collaterals and its application |
| 02/06/2002 | CN1334112A Chinese medicine for treaitng coronary heart disease |
| 02/06/2002 | CN1334097A Health-care product for improving visual function |
| 02/06/2002 | CN1334085A Application of tetracyclines antibiotics in preparing medicine to treat retinal ischemic injury |
| 02/06/2002 | CN1334084A Medicine composition containing pyrroloquinolinequinone for treating saturnism |
| 02/06/2002 | CN1334083A Nitroimiazoles colon target medicine and its preparing process |
| 02/06/2002 | CN1334082A Chinese-medical suppository for treating vaginal looseness |
| 02/06/2002 | CN1334081A Parkinson's disease treating preparing contg. astrocyte function improver as active component |
| 02/06/2002 | CN1334080A Slow-release wanlafacine hydrochloride tablet and its preparing process |
| 02/06/2002 | CN1334031A Use of alpha-keto-enamine derivatives as ingredient |
| 02/06/2002 | CN1078889C Non-pepitde tachykinin receptor antagonists |
| 02/06/2002 | CN1078887C Sulfur-contg. di-tert-bytylphenol compounds useful as anti-inflammatory agents |
| 02/06/2002 | CN1078886C Inhibitor of inhibiting generation of beta-amyloid |
| 02/05/2002 | WO2002034268A1 Sustained-release preparation containing 5-acetyl-4,6-dimethyl-2-[2-[4-(2-methoxyphenyl)piperazinyl]ethylamino]pyrimidine trihydrochloride as active ingredient |
| 02/05/2002 | US6344581 Method of prostaglandin synthesis |
| 02/05/2002 | US6344571 Therapy for mammary or colon tumors |
| 02/05/2002 | US6344570 Substituted urea derivatives as cell adhesion inhibitors |
| 02/05/2002 | US6344566 Method for producing enantiomer-free N-methyl-N-[(1S)-1-phenyl-2-((3S)-3-hydroxypyrolidine-1-yl)ethyl]-2,2-diphenylacetamide |
| 02/05/2002 | US6344563 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 02/05/2002 | US6344562 Thiazole derivatives |
| 02/05/2002 | US6344561 O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
| 02/05/2002 | US6344558 Analgesics |
| 02/05/2002 | US6344487 Nortripyline |
| 02/05/2002 | US6344486 Anticoagulants |
| 02/05/2002 | US6344485 Method for treating glaucoma |
| 02/05/2002 | US6344484 Treatment of tumor growth, metastasis, osteoporosis, restenosis, inflammation, macular degeneration, diabetic retinopathy, and rheumatoid arthritis |
| 02/05/2002 | US6344483 Halogenated amidino amino acid deviratives useful as nitric oxide synthase inhibitors |
| 02/05/2002 | US6344482 Omega-3 fatty acids in the treatment of bipolar disorder |
| 02/05/2002 | US6344481 Thyromimetic antiobesity agents |
| 02/05/2002 | US6344480 Oral analgesic compositions |
| 02/05/2002 | US6344479 Amino acid salt of ibuprofen |
| 02/05/2002 | US6344478 Mixture with carbonic anhydrase inhibitor |
| 02/05/2002 | US6344477 Prostaglandin e agonists for treatment of dry eye |
| 02/05/2002 | US6344476 Inhibition of p38 kinase activity by aryl ureas |
| 02/05/2002 | US6344475 Cystic fibrosis |
| 02/05/2002 | US6344474 Use of central cannabinoid receptor antagonists for regulating appetence |
| 02/05/2002 | US6344471 Diisopropyl fluorophosphate (dfp), treatment of cognitive disorders, depression, schizophrenia and anxiety. |
| 02/05/2002 | US6344470 Aminothiazole derivatives, method of preparation and pharmaceutical compositions containing same |
| 02/05/2002 | US6344468 Substituted isoindolones and their use as cyclic GMP modulators in medicaments |
| 02/05/2002 | US6344467 Antiasthmatic, antiallergic and immunosuppressant/immunomodulating properties |
| 02/05/2002 | US6344466 Antithrombotic activity, use in inhibiting loss of blood platelets, inhibiting formation of blood platelet aggregates, inhibiting formation of fibrin, anticoagulants |
| 02/05/2002 | US6344465 Inhibitors of IMPDH enzyme |
| 02/05/2002 | US6344464 Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelination |
| 02/05/2002 | US6344463 Skin disorders, acne |
| 02/05/2002 | US6344462 Heterocyclic compounds as bradykinin antagonists |
| 02/05/2002 | US6344461 Treating skin wrinkles/fine lines with calcium channel inhibitors |
| 02/05/2002 | US6344459 Treating cancer, restenosis, atherosclerosis, endometriosis, and psoriasis |
| 02/05/2002 | US6344456 Piperazinone derivatives and their uses |
| 02/05/2002 | US6344455 Treating cancer, atherosclerosis, restenosis, endometriosis, and psoriasis |
| 02/05/2002 | US6344452 Gastrin receptor antagonist, gastrointestinal disorders, etc |
| 02/05/2002 | US6344451 Pyrrolobenzodiazepine carboxyamide vasopressin agonists |
| 02/05/2002 | US6344450 Lactam compounds and their use as inhibitors of serine proteases and method |
| 02/05/2002 | US6344449 Headache and morphine dependence |
| 02/05/2002 | US6344448 Composition for the treatment of hair loss |
| 02/05/2002 | US6344447 Administering mixture of nucleosides; anticancer agent |
| 02/05/2002 | US6344444 Arginine-silicate-inositol complex and use thereof |
| 02/05/2002 | US6344441 Lipoprotein-regulating medicaments |
| 02/05/2002 | US6344440 Antisecretory factor peptides regulating pathological permeability changes |
| 02/05/2002 | US6344439 Agents for promoting bone formation |
| 02/05/2002 | US6344437 Medicine drink food and feed having an action of strengthening bone |
| 02/05/2002 | US6344358 Administering somatostatin releasing agent to treat brain, psychological and nervous system disorders such as schizophrenia, amnesia, bipolar disorder, alzheimer*s disease and parkinson*s disease |
| 02/05/2002 | US6344321 Nucleic acid ligands which bind to hepatocyte growth factor/scatter factor (HGF/SF) or its receptor c-met |
| 02/05/2002 | US6344318 A selex method determining three dimensional structure of nucleic acid ligands by identifying a ligand to a specific target and modifying the nucleotides with a monomer to allow the ligand to mimic the structure and bind the target |
| 02/05/2002 | US6344314 Determined DNA sequenced derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions |
| 02/05/2002 | US6344220 Cayenne, turmeric, ginger, yucca, devil's claw, nettle leaf, black cohosh, alfalfa, celery seeds, glucosamine hydrochloride and mucopolysaccharides; antiartthritic, antiinflamatory agents, analgesics, immunosupressants |
| 02/05/2002 | US6344215 Methylphenidate modified release formulations |
| 02/05/2002 | US6344214 Method for retarding and ameliorating fever blisters and canker sores |
| 02/05/2002 | US6344212 Method of providing sustained analgesia with buprenorphine |
| 02/05/2002 | US6344210 Composition for freshening nostrils and sinus cavities |
| 02/05/2002 | US6344203 Mimicking peptides in cancer therapy |
| 02/05/2002 | US6344202 Nucleotide sequence encodes major outer membrane proteins, generates antibodies that react with promoter sequence for expression in the host; drugs, vaccines |
| 02/05/2002 | US6344201 Inhibitors of e. coli and shigella enterotoxins; used for drugs and dna vaccines |
| 02/05/2002 | US6344190 Multiple separate applications to the nail of natural plant derivatives including camphor, menthol, eucalyptus oil, and thymol in a topical carrier, |
| 02/05/2002 | US6344181 Decreased endogenous nitric oxide activation |
| 02/05/2002 | CA2343023C Process for preparing nizatidine utilizing toluene as solvent |
| 02/05/2002 | CA2242552C A process for preparing a controlled release composition |
| 02/05/2002 | CA2219605C Method of stimulating gastrointestinal motility with ellagic acid |
| 02/05/2002 | CA2218289C Cd45rb binding compounds for the prevention of transplant rejection |
| 02/05/2002 | CA2217513C Pharmaceutical agents for the treatment of alzheimer's disease |
| 02/05/2002 | CA2150714C Syndecan stimulation of cellular differentiation |
| 02/05/2002 | CA2150464C A pharmaceutical formulation for intraduodenal administration |
| 02/05/2002 | CA2123403C Acyclic ethylenediamine derivatives as substance p receptor antagonists |
| 02/05/2002 | CA2121123C Anti-seborrhoeic formulation |
| 02/05/2002 | CA2110993C Food composition for inhibiting the formation of an intestinal putrefactive product |
| 02/05/2002 | CA2110290C Microspheres useful for therapeutic vascular occlusions and injectable solutions containing the same |
| 02/05/2002 | CA2082074C 1h-substituted-1,2,4-triazole compounds for treatment of cardiovascular disorders |
| 02/05/2002 | CA2081330C 3-indolyl thioacetate derivatives |